Literature DB >> 24679908

The affordable care act and treatment for "substance use disorders:" implications of ending segregated behavioral healthcare.

A Thomas McLellan1, Abigail Mason Woodworth2.   

Abstract

The Affordable Care Act (2010) and the Mental Health Parity and Addiction Equity Act (2008) are expected to transform substance abuse prevention and treatment in the United States. In this paper, we outline the potential disruption to the existing specialty care delivery system, and describe the opportunities for treatment providers and health services researchers.
Copyright © 2014 Elsevier Inc. All rights reserved.

Mesh：

Year:  2014        PMID： 24679908     DOI： 10.1016/j.jsat.2014.02.001

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN： 0740-5472


  36 in total

1.  Integrated care models and behavioral health care utilization: Quasi-experimental evidence from Medicaid health homes.

Authors:  Chandler McClellan; Johanna Catherine Maclean; Brendan Saloner; Emma E McGinty; Michael F Pesko
Journal:  Health Econ       Date:  2020-04-22       Impact factor: 3.046

Review 2.  Using e-technologies in clinical trials.

Authors:  Carmen Rosa; Aimee N C Campbell; Gloria M Miele; Meg Brunner; Erin L Winstanley
Journal:  Contemp Clin Trials       Date:  2015-07-12       Impact factor: 2.226

3.  Potential radiating effects of misusing substances among medical patients receiving brief intervention.

Authors:  Jan Gryczynski; Shannon Gwin Mitchell; Steven J Ondersma; Kevin E O'Grady; Robert P Schwartz
Journal:  J Subst Abuse Treat       Date:  2015-02-23

4.  Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System.

Authors:  Cynthia I Campbell; Sujaya Parthasarathy; Kelly C Young-Wolff; Derek D Satre
Journal:  J Psychoactive Drugs       Date:  2017-04-20

5.  The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act.

Authors:  Johanna Catherine Maclean; Brendan Saloner
Journal:  J Policy Anal Manage       Date:  2019

6.  Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.

Authors:  Bryan Hartzler; Julia C Dombrowski; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Behav       Date:  2017-04

7.  States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence.

Authors:  Hannah K Knudsen; Michelle R Lofwall; Jennifer R Havens; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2015-10-09       Impact factor: 4.492

8.  Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment.

Authors:  Hannah K Knudsen; Jamie L Studts
Journal:  J Behav Health Serv Res       Date:  2019-01       Impact factor: 1.505

9.  Adopting the 'cascade of care' framework: an opportunity to close the implementation gap in addiction care?

Authors:  M Eugenia Socías; Nora Volkow; Evan Wood
Journal:  Addiction       Date:  2016-07-13       Impact factor: 6.526

10.  Understanding Patterns Of High-Cost Health Care Use Across Different Substance User Groups.

Authors:  Jan Gryczynski; Robert P Schwartz; Kevin E O'Grady; Lauren Restivo; Shannon G Mitchell; Jerome H Jaffe
Journal:  Health Aff (Millwood)       Date:  2016-01       Impact factor: 6.301
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.